Ticker >

Sanofi India share price

Sanofi India Ltd.

NSE: SANOFI BSE: 500674 SECTOR: Pharmaceuticals & Drugs  91k   346   43

8113.95
+153.15 (1.92%)
NSE: 28 Mar 4:00 PM

Price Summary

Today's High

₹ 8200

Today's Low

₹ 7970

52 Week High

₹ 9380

52 Week Low

₹ 5400

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

18686.93 Cr.

Enterprise Value

17670.03 Cr.

No. of Shares

2.3 Cr.

P/E

30.98

P/B

18.4

Face Value

₹ 10

Div. Yield

2.04 %

Book Value (TTM)

₹  440.95

CASH

1016.9 Cr.

DEBT

0 Cr.

Promoter Holding

60.4 %

EPS (TTM)

₹  261.91

Sales Growth

-6.31%

ROE

36.73 %

ROCE

49.47%

Profit Growth

-34.29 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Sanofi India Ltd.

Allegra Avil Combiflam Clexane Cardace Daonil Lantus Taxotere Soframycin Arava Lasix

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-6.31%
3 Year-3.37%
5 Year2.37%

Profit Growth

1 Year-34.29%
3 Year14.43%
5 Year13.74%

ROE%

1 Year36.73%
3 Year34.26%
5 Year27.8%

ROCE %

1 Year49.47%
3 Year45.74%
5 Year38.34%

Debt/Equity

0

Price to Cash Flow

46.87

Interest Cover Ratio

509.411764705882

CFO/PAT (5 Yr. Avg.)

0.829914710650596

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2023 60.4 0
Sep 2023 60.4 0
Jun 2023 60.4 0
Mar 2023 60.4 0
Dec 2022 60.4 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 34.2573120157988% over the past 3 years.
  • Company has been maintaining healthy ROCE of 45.7378532454357% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 509.411764705882.
  • The Company has been maintaining an effective average operating margins of 23.6238553879256% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -41.8150436931753 days.
  • The company has a high promoter holding of 60.4%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 15.9699357946118.

 Limitations

  • The company has shown a poor revenue growth of -3.37469384239334% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 671.9 736.5 706.1 714.6 693.9
Total Expenditure 505 506.6 527.9 506.1 506.5
Operating Profit 166.9 229.9 178.2 208.5 187.4
Other Income 20 25.8 15.7 11.8 12
Interest 0.4 0.3 0.7 0.3 0.4
Depreciation 10 9.7 9.8 9.9 10.2
Exceptional Items 13.9 17.8 0 0 0
Profit Before Tax 190.4 263.5 183.4 210.1 188.8
Tax 59.5 73.1 60.5 57.9 51.1
Profit After Tax 130.9 190.4 122.9 152.2 137.7
Adjusted EPS (Rs) 56.91 82.78 53.43 66.17 59.87

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022
Net Sales 2770.8 3070.6 2901.9 2956.6 2770.1
Total Expenditure 2147.9 2405.3 2188.8 2194.3 2067.2
Operating Profit 622.9 665.3 713.1 762.3 702.9
Other Income 90.3 94.1 89.8 74.6 73
Interest 0.7 0.3 1.8 1.8 1.7
Depreciation 102.7 99.9 82.2 66.7 41.9
Exceptional Items 0 -59.3 -41.7 489.2 132
Profit Before Tax 609.8 599.9 677.2 1257.6 864.3
Tax 229.2 185.7 199.6 313.2 243.7
Net Profit 380.6 414.2 477.6 944.4 620.6
Adjusted EPS (Rs.) 165.48 180.09 207.65 410.61 269.83

Balance Sheet (All Figures are in Crores.)

Particulars Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022
Equity and Liabilities
Share Capital 23 23 23 23 23
Total Reserves 2196.2 2419.3 2096 2202.6 1252.8
Borrowings 0 0 0 0 0
Other N/C liabilities 1357.1 1124.1 1280.3 1038.9 808.7
Current liabilities 1193 1673.5 1694.1 2289.9 2742.5
Total Liabilities 4769.3 5239.9 5093.4 5555.3 4827.9
Assets
Net Block 732.8 498.7 464.1 334.1 305.5
Capital WIP 16.4 12.7 6.3 8.9 18.8
Intangible WIP 4.7 4.7 3.7 3.9 4.8
Investments 0.2 0 0 0 0
Loans & Advances 1843.8 1617.2 1773.1 1521.4 877.7
Other N/C Assets 9.7 7.2 5.6 11.8 9
Current Assets 2161.7 3099.4 2840.6 3675.2 3612.1
Total Assets 4769.3 5239.9 5093.4 5555.3 4827.9
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022
Profit from operations 609.8 599.9 677.2 1257.6 864.3
Adjustment 35.8 78.4 65 -482 -159.3
Changes in Assets & Liabilities -27.6 -37.7 62.2 68.1 -45.6
Tax Paid -244.1 -228.3 -193.3 -284.9 -260.7
Operating Cash Flow 373.9 412.3 611.1 558.8 398.7
Investing Cash Flow -73.1 65.7 276.4 630.8 650.9
Financing Cash Flow -197.2 -183.2 -810 -849 -1582.7
Net Cash Flow 103.6 294.8 77.5 340.6 -533.1

Corporate Actions

Investors Details

PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
promoters 60.40 60.40 60.40 60.40 60.40
hoechst gmbh 60.37 60.37 - 60.37 60.37
sanofi 0.02 0.02 0.02 0.02 0.02
hoescht gmbh - - 60.37 - -
PARTICULARS Dec 2022% Mar 2023% Jun 2023% Sep 2023% Dec 2023%
investors 39.60 39.60 39.60 39.60 39.60
aditya birla sun life tru... - 2.76 2.43 2.62 3.68
bajaj allianz life insura... 1.65 1.68 1.66 - 1.68
general insurance corpora... 1.42 1.51 1.53 - 1.43
hdfc life insurance compa... 1.91 - - - 1.26
investor education and pr... - - 0.18 0.18 0.19
life insurance corporatio... 5.95 - - - 5.95
llp 0.02 0.02 0.02 0.02 0.02
nippon life india trustee... - - 3.31 3.41 3.83
sbi contra fund 1.78 1.79 1.79 1.79 1.79
bajaj allianz life insura... - - - 1.65 -
general insurance coporat... - - - 1.53 -
hdfc life insurance compa... - 1.94 1.92 1.92 -
life insurance corporatio... - 5.95 5.95 5.95 -
icici prudential value di... - 1.30 - - -
investor education and pr... 0.18 0.18 - - -
nippon life india trustee... - 2.08 - - -
aditya birla sun life tru... 2.79 - - - -
icici prudential pharma h... 1.22 - - - -
nippon life india trustee... 2.09 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Sanofi India enters into partnership with Cipla 27 Mar 2024, 11:42AM Sanofi India informs about loss of share certificate12 Mar 2024, 5:20PM Sanofi India informs about loss of share certificates11 Mar 2024, 12:12PM Sanofi India informs about outcome of analyst meet26 Feb 2024, 5:15PM Sanofi India - Quaterly Results23 Feb 2024, 6:08PM Sanofi India - Quaterly Results23 Feb 2024, 6:08PM Sanofi India - Quaterly Results23 Feb 2024, 6:08PM Sanofi India informs about newspaper publication20 Feb 2024, 4:37PM Sanofi India informs about loss of share certificates1 Feb 2024, 12:03PM Sanofi India informs about newspaper publication16 Jan 2024, 5:13PM Sanofi India informs about disclosure 29 Nov 2023, 12:29PM Sanofi India - Quaterly Results8 Nov 2023, 5:35PM Sanofi India - Quaterly Results8 Nov 2023, 5:35PM Sanofi India submits board meeting intimation 19 Oct 2023, 4:49PM Sanofi India informs about change in management17 Oct 2023, 12:40PM Sanofi India informs about investor awareness on ODR mechanism23 Sep 2023, 4:22PM Sanofi India informs about issuance of duplicate share certificates22 Aug 2023, 2:30PM Sanofi India - Quaterly Results10 Aug 2023, 3:56PM Sanofi India - Quaterly Results10 Aug 2023, 3:56PM Sanofi India - Quaterly Results10 Aug 2023, 3:56PM Sanofi India informs about board meeting26 Jul 2023, 2:40PM Sanofi India informs about resignation of non-executive director 20 Jul 2023, 12:36PM Sanofi India informs about issuance of duplicate share certificates19 Jul 2023, 4:46PM Sanofi India informs about closure of trading window22 Jun 2023, 1:27PM Sanofi India informs about details of loss of certificate 19 Jun 2023, 4:59PM Sanofi India informs about minutes of 67th AGM31 May 2023, 4:40PM Sanofi India informs about newspaper publication29 May 2023, 12:22PM Sanofi India gets nod to demerge consumer healthcare business into separate entity10 May 2023, 5:00PM Sanofi India - Quaterly Results10 May 2023, 2:10PM Sanofi India - Quaterly Results10 May 2023, 2:10PM Sanofi India - Quaterly Results10 May 2023, 2:10PM Sanofi India informs about details of loss of certificate 3 Apr 2023, 5:18PM Sanofi India informs about loss of share certificate23 Mar 2023, 4:01PM Sanofi India informs about newspaper publication27 Feb 2023, 3:55PM Sanofi India - Quaterly Results23 Feb 2023, 5:13PM Sanofi India - Quaterly Results23 Feb 2023, 5:13PM Sanofi India - Quaterly Results23 Feb 2023, 5:13PM Sanofi India informs about details of loss of certificate 18 Feb 2023, 11:51AM Sanofi India informs about loss of share certificates6 Feb 2023, 1:12PM Sanofi India informs about certificate27 Jan 2023, 12:49PM Sanofi India informs about certificate9 Jan 2023, 4:07PM Sanofi India informs about loss of share certificate 3 Jan 2023, 4:38PM Sanofi India informs about details of loss of certificate 18 Nov 2022, 5:12PM Sanofi India - Quaterly Results3 Nov 2022, 5:19PM Sanofi India - Quaterly Results3 Nov 2022, 5:19PM Sanofi India - Quaterly Results3 Nov 2022, 5:19PM Sanofi India informs about board meeting 21 Oct 2022, 12:16PM Sanofi India informs about loss of share certificate11 Oct 2022, 12:35PM Sanofi India informs about loss of share certificate6 Oct 2022, 12:12PM Sanofi India informs about certificate 6 Oct 2022, 10:39AM

Sanofi India Stock Price Analysis and Quick Research Report. Is Sanofi India an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Sanofi India and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Sanofi India cash from the operating activity was Rs 398.7 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Sanofi India has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Sanofi India , the EPS growth was -34.2863168754096 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Sanofi India has OPM of 25.3745352153352 % which is a good sign for profitability.
     
  • ROE: Sanofi India have a healthy ROE of 36.7316741144092 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Sanofi India is Rs 8113.95. One can use valuation calculators of ticker to know if Sanofi India share price is undervalued or overvalued.
Last Updated on:
Brief about Sanofi India

Sanofi India Ltd Financials: Check Share price, Balance Sheet, Annual report and Quarterly Results for company analysis 

Sanofi India Ltd Share Price

 

Sanofi India Ltd. is a pharmaceutical company operating in India. In this section, we will analyze the share price performance of Sanofi India Ltd. Ticker pre-built screening tools provide investors with real-time updates on the share price movements of the company.

Sanofi India Ltd Balance Sheet

Analyzing the balance sheet of Sanofi India Ltd. is crucial for long-term stock investors. It helps in understanding the financial position of the company. However, we do not provide specific financial data points about the stock. You can access the balance sheet of Sanofi India Ltd. on Ticker for a comprehensive analysis.

Sanofi India Ltd Annual Report

The annual report of Sanofi India Ltd. is a valuable resource for investors looking to analyze the company's performance over the years. You can download the annual report from Ticker to gain insights into the company's operations, financials, and future prospects.

Sanofi India Ltd Dividend

Investors seeking long-term investment opportunities often consider dividends as an important factor. Sanofi India Ltd. has a track record of consistent dividend payments. You can find more information about the dividend history and yield of Sanofi India Ltd. on Ticker.

Sanofi India Ltd Quarterly Result

Analyzing the quarterly results of Sanofi India Ltd. provides investors with the latest information on the company's financial performance. Ticker offers downloadable quarterly results, allowing investors to stay updated with the latest developments and make informed decisions.

Sanofi India Ltd Stock Price

Tracking the stock price of Sanofi India Ltd. is essential for investors. Ticker provides real-time stock price information, enabling investors to monitor fluctuations and make timely investment decisions. You can also access historical price charts to analyze the stock's performance over time.

Sanofi India Ltd Price Chart

The price chart of Sanofi India Ltd. shows the historical performance of the stock. By visually analyzing the price movements, investors can identify patterns and trends that may guide their investment decisions. You can access the price chart on Ticker for a comprehensive stock analysis.

Sanofi India Ltd News

Staying updated with the latest news and developments related to Sanofi India Ltd. is crucial for investors. Ticker provides a dedicated news section where you can find the latest updates, market trends, and announcements regarding Sanofi India Ltd.

Sanofi India Ltd Concall Transcripts

Concall transcripts provide valuable insights into the company's performance and management's outlook. At Ticker, you can access the concall transcripts of Sanofi India Ltd., allowing investors to understand the discussions held during the conference calls and gain deeper insights into the company's strategies.

Sanofi India Ltd Investor Presentations

Investor presentations offer an in-depth understanding of Sanofi India Ltd.'s business strategies, financials, and future prospects. Ticker provides access to investor presentations, enabling investors to make informed investment decisions based on comprehensive information.

Sanofi India Ltd Promoters

Understanding the promoters of a company is crucial for investors. The promoters of Sanofi India Ltd. play a significant role in the company's operations and decision-making. You can find information about the promoters of Sanofi India Ltd. on Ticker.

Sanofi India Ltd Shareholders

Analyzing the shareholder structure of Sanofi India Ltd. provides insights into the ownership pattern and the distribution of shares. Ticker offers details on the major shareholders of Sanofi India Ltd., helping investors understand the dynamics of ownership within the company.

Read More
X